These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1625719)

  • 1. The maturation of differentiation therapy.
    Cheson BD
    N Engl J Med; 1992 Aug; 327(6):422-4. PubMed ID: 1625719
    [No Abstract]   [Full Text] [Related]  

  • 2. Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
    Koike T; Tatewaki W; Aoki A; Yoshimoto H; Yagisawa K; Hashimoto S; Furukawa T; Saitoh H; Takahashi M; Yang LB
    N Engl J Med; 1992 Aug; 327(6):385-7. PubMed ID: 1625712
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute promyelocytic leukemia: a paradigm for differentiation therapy.
    Grimwade D; Mistry AR; Solomon E; Guidez F
    Cancer Treat Res; 2010; 145():219-35. PubMed ID: 20306254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cytokines on hyperleukocytosis associated with acute promyelocytic leukemia induced by all-trans retinoic acid therapy].
    Hino K; Nakamaki T
    Rinsho Ketsueki; 1996 Sep; 37(9):770-6. PubMed ID: 8914460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid syndrome in acute promyelocytic leukemia.
    Sentero D; Hosenpud J
    Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lessons learned from differentiation therapy with all-trans retinoic acid in the JALSG APL studies].
    Asou N
    Rinsho Ketsueki; 2004 Feb; 45(2):115-24. PubMed ID: 15045819
    [No Abstract]   [Full Text] [Related]  

  • 7. Tretinoin in the treatment of acute promyelocytic leukemia.
    Wong WM
    Cancer Pract; 1996; 4(4):220-3. PubMed ID: 8900766
    [No Abstract]   [Full Text] [Related]  

  • 8. All trans retinoic acid as a targeting drug for differentiation therapy in acute promyelocytic leukemia.
    Degos L
    Cancer Treat Res; 1993; 64():1-13. PubMed ID: 8095789
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T
    Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for basophilic differentiation of acute promyelocytic leukaemia cells during arsenic trioxide therapy.
    Masamoto Y; Nannya Y; Arai S; Koike Y; Hangaishi A; Yatomi Y; Kurokawa M
    Br J Haematol; 2009 Mar; 144(5):798-9. PubMed ID: 19036092
    [No Abstract]   [Full Text] [Related]  

  • 11. Atiprimod: a multi-functional drug candidate for myeloid and other malignancies.
    Shailubhai K
    Leuk Res; 2007 Jan; 31(1):9-10. PubMed ID: 16860863
    [No Abstract]   [Full Text] [Related]  

  • 12. Auer rods and differentiation in acute promyelocytic leukemia.
    Zassadowski F; Ades L; Schlageter MH; Chevret S; Guillemot I; Fenaux P; Chomienne C; Cassinat B
    Br J Haematol; 2008 Sep; 142(6):998-1000. PubMed ID: 18544082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Leukemia specific chimeric protein as a target molecule for chemotherapy].
    Naoe T
    Rinsho Ketsueki; 1998 Feb; 39(2):105-6. PubMed ID: 9545811
    [No Abstract]   [Full Text] [Related]  

  • 14. Synopsis of the discussions of the workshop: hematology.
    Degos L
    Leukemia; 1994; 8 Suppl 3():S77-9. PubMed ID: 7808031
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute promyelocytic leukemia--weapons of mass differentiation.
    Licht JD
    N Engl J Med; 2009 Feb; 360(9):928-30. PubMed ID: 19246367
    [No Abstract]   [Full Text] [Related]  

  • 16. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M; Harrison K; Barton K; Nand S; Alkan S
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.
    Martínez-Chamorro C; Martínez E; Gil-Fernández JJ; Alonso A; Escudero A; Fernández-Rañada JM
    Haematologica; 2002 Feb; 87(2):ECR08. PubMed ID: 11836177
    [No Abstract]   [Full Text] [Related]  

  • 18. All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
    Schmitt K; Zoubek A; Schwarz R; Tulzer G; Koller E; Krieger O; Lutz D; Gadner H
    Med Pediatr Oncol; 1996 Apr; 26(4):254-7. PubMed ID: 8600337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and overcoming of ATRA resistance in acute promyelocytic leukemia.
    Lo Coco F
    Haematologica; 1999 Nov; 84(11):961-2. PubMed ID: 10553153
    [No Abstract]   [Full Text] [Related]  

  • 20. [Induction of differentiation of human promyelocytic leukemia (HL-60) cells by new retinoid R-81001].
    Jiao L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Apr; 11(2):102-6. PubMed ID: 2528415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.